Hepatitis B News and Research

Latest Hepatitis B News and Research

Genetic relic of the 'Black Death' may provide clues for treating fatal liver scarring

A gene mutation that is believed to have safeguarded some people in 14th century Europe from the bubonic plague today may be protecting HIV patients co-infected with hepatitis C from potentially fatal liver scarring, says a University of Cincinnati College of Medicine physician-scientist.

3 Dec 2018

Is Europe on track to end AIDS by 2020?

From diagnosis of HIV to successful viral suppression: in a rapid communication published in Eurosurveillance today, ECDC and co-authors from Public Health England and The National AIDS Trust summarise the progress towards HIV elimination in 52 countries in Europe and Central Asia.

30 Nov 2018

ECDC and WHO release latest data on HIV epidemic in the European Region

The European Centre for Disease Prevention and Control and the WHO Regional Office for Europe release the latest data on the HIV epidemic in the European Region, marking the 30th anniversary of World AIDS Day.

29 Nov 2018

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

The U.S. Food and Drug Administration today approved Truxima (rituximab-abbs) as the first biosimilar to Rituxan (rituximab) for the treatment of adult patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL) to be used as a single agent or in combination with chemotherapy.

29 Nov 2018

HIV epidemic raging across Europe finds report

A new report has found that there is an HIV epidemic across Europe especially in Eastern Europe. The new diagnoses rose in 2017 the report said but the speed of rise has slowed.

28 Nov 2018

First modeling system developed for testing age-specific human immune responses to vaccines

A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body. The practical, cost-effective new platform, using all human components, is expected to accelerate and de-risk the development, assessment and selection of vaccines.

20 Nov 2018

Routine HCV testing in correctional facilities can best identify and treat disease, say researchers

Results from a new study led by Boston Medical Center (BMC) found routine Hepatitis C testing identified a significant number of cases that would have been missed by targeted testing among a population of individuals in Washington State prisons.

20 Nov 2018

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

The Foundation for Innovative New Diagnostics today announced awards to support the development, manufacture and feasibility testing of two prototype hepatitis C virus core antigen immunoassays for confirmatory HCV diagnosis at the point of care.

16 Nov 2018

Benefit-harm balance of hepatitis B and C screening is unclear due to lack of informative evidence

Hepatitis B and hepatitis C are viral infections, which are mostly transmitted by blood. Often unnoticed, they can become chronic, causing irreversible damage to the liver.

15 Nov 2018

NIH researchers shed light on causes of HBV-associated acute liver failure

National Institutes of Health scientists and their collaborators found that hepatitis B virus-associated acute liver failure--a rare condition that can turn fatal within days without liver transplantation--results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response in the patient's liver that is mainly sustained by antibody-producing B cells.

14 Nov 2018

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

Hepatitis C virus (HCV) infection is the major cause of hepatocellular carcinoma (HCC) and was estimated to be responsible for 745,000 deaths in 2012.

13 Nov 2018

Study shows how pneumococci challenge the immune system

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis.

12 Nov 2018

Bfr organizes symposia for research on viruses and antimicrobial resistance in food chain

Against this background, the German Federal Institute for Risk Assessment is organising two symposia dealing with microbial risks in food in November 2018: "Food-associated viruses" on 7 November and "Antimicrobial resistance in the food chain" on 8/9 November.

9 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

New study to evaluate human immune system's response to influenza

The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow - and that is one spot where scientists will be looking to understand the human immune system's response to influenza in a groundbreaking new study led by the Human Vaccines Project.

1 Nov 2018

Hepatitis B News and Research

Latest Hepatitis B News and Research

Genetic relic of the 'Black Death' may provide clues for treating fatal liver scarring

Is Europe on track to end AIDS by 2020?

ECDC and WHO release latest data on HIV epidemic in the European Region

First biosimilar approved by FDA for treatment of adult patients with non-Hodgkin’s lymphoma

HIV epidemic raging across Europe finds report

First modeling system developed for testing age-specific human immune responses to vaccines

Routine HCV testing in correctional facilities can best identify and treat disease, say researchers

FIND explores new diagnostic assays for confirmatory HCV diagnosis in community settings

Benefit-harm balance of hepatitis B and C screening is unclear due to lack of informative evidence

NIH researchers shed light on causes of HBV-associated acute liver failure

Study shows new emerging role of osteopontin in HCV-related hepatocellular carcinoma

Study shows how pneumococci challenge the immune system

Bfr organizes symposia for research on viruses and antimicrobial resistance in food chain

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

New study to evaluate human immune system's response to influenza

Study offers hope of early detection, treatment of liver cancer

Research reveals high stability of hepatitis B viruses

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

Researchers identify new potential target to inhibit progression of liver disease

Researchers find improvement in liver transplant survival rate among older recipients

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Hepatitis B News and Research

Latest Hepatitis B News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in